Effects of sulfhydryl compounds on interleukin-1-induced vascular endothelial growth factor production in human synovial stromal cells

Biol Pharm Bull. 2000 May;23(5):663-5. doi: 10.1248/bpb.23.663.

Abstract

We investigated the effects of various sulfhydryl compounds on interleukin-1 (IL-1)-induced vascular endothelial growth factor (VEGF) production in human synovial stromal cells (HSSC). HSSC stimulated by IL-1beta (100 ng/ml) produced VEGF and interleukin-6 (IL-6) in vitro. Monosulfhydryl compounds, N-acetylcysteine, D-penicillamine, tiopronin and the bucillamine-like disulfhydryl compound, compound A scarcely affected VEGF or IL-6 production at concentrations of 10(-5) and 10(-4) M. However, the disulfhydryl compound, bucillamine inhibited VEGF production but not IL-6 production at concentrations of 10(-5) and 10(-4) M. These results suggest that bucillamine may be a selective inhibitor of IL-1-induced VEGF production in HSSC, and that inhibition of VEGF production may require not only SH groups but also a specific chemical structure.

MeSH terms

  • Acetylcysteine / pharmacology
  • Cells, Cultured
  • Cysteine / analogs & derivatives
  • Cysteine / pharmacology
  • Endothelial Growth Factors / biosynthesis*
  • Humans
  • Interleukin-1 / pharmacology
  • Lymphokines / biosynthesis*
  • Penicillamine / pharmacology
  • Stromal Cells / drug effects
  • Stromal Cells / metabolism
  • Sulfhydryl Compounds / pharmacology*
  • Synovial Membrane / cytology
  • Synovial Membrane / drug effects*
  • Tiopronin / pharmacology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Interleukin-1
  • Lymphokines
  • Sulfhydryl Compounds
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Tiopronin
  • Penicillamine
  • Cysteine
  • bucillamine
  • Acetylcysteine